Skip to content
All articlesSexual Health & Intimacy7 min read
Sexual Health & Intimacy

PT-141 for Women: What Bremelanotide Does for Desire in 2026

A clear, credible look at the one desire peptide with a real clinical record in women, and how pru prescribes it.

A confident, relaxed woman in her late 30s at home in soft morning light, calm and at ease with a warm, unguarded smile
Image: pru

Yes, PT-141 (bremelanotide) is studied in women, and it's the desire peptide with the strongest clinical record here. It works on desire pathways in the brain rather than on blood flow, so it targets wanting, not just the physical side of arousal. The branded version, Vyleesi, is FDA-approved for premenopausal women who have low desire plus distress. pru offers compounded, pharmacy-grade PT-141, prescribed by a licensed physician. If low desire has been weighing on you, looking into it is a smart move, and here's what to know first.

Does PT-141 work for women?

PT-141 is studied specifically in women, which sets it apart from most peptides. Its active ingredient, bremelanotide, is the same molecule in Vyleesi, an FDA-approved injection for premenopausal women with acquired, generalized low sexual desire and related distress. In the phase 3 RECONNECT trials, about 1,200 women used it on demand before intimacy. It's thought to work on desire signaling in the brain, not on blood flow.

How popular is PT-141?People search for PT-141 about 15,000 times a month in the US, a steadily searched peptide, and search interest is climbing fast (2026 search data). See the Peptide Popularity Report for the full ranking.

Quick answerPT-141 is a peptide studied for low sexual desire in women. It acts on brain desire pathways and is used on demand, not daily. pru offers it as compounded, pharmacy-grade PT-141, confirmed by a licensed physician.

DetailWhat research and labeling show
What it isA lab-made peptide (bremelanotide) that acts on desire pathways in the brain
How it's usedA small under-the-skin injection, taken on demand before intimacy
Studied dose (branded)1.75 mg about 45 minutes before activity; no more than one dose in 24 hours
Studied in~1,200 premenopausal women in the RECONNECT trials
Most common effectNausea, reported by about 40% in trials, usually easing within a few hours
Works byBrain desire signaling, not blood flow like ED drugs
PT-141 for women at a glance

What is PT-141 (bremelanotide)?

PT-141, also called bremelanotide, is a small synthetic peptide that acts on the brain's desire and arousal signaling. It's a melanocortin agonist, meaning it switches on melanocortin receptors (mainly MC4R) in the central nervous system. Those receptors sit on pathways tied to sexual motivation. This is why PT-141 is grouped with desire peptides, not with blood-flow drugs.

PT-141a melanocortin agonistActs on desirepathwaysin the brainDesireand arousalWorks onthe brainNot bloodflow like ED drugs
Illustrative.

The branded, FDA-approved product is Vyleesi, cleared in 2019 for premenopausal women. pru does not offer Vyleesi. pru offers compounded PT-141, which is pharmacy-grade and made by a licensed 503A pharmacy. Compounded PT-141 is not the branded drug and shouldn't be treated as identical to it. For a fuller primer, see the PT-141 guide.

How does PT-141 work in women?

PT-141 works from the top down, in the brain. When bremelanotide activates MC4R receptors, it's thought to nudge dopamine signaling in brain regions like the medial preoptic area, which are linked to sexual motivation. In plain terms, it's studied for the mental side of desire, the wanting, rather than the mechanics of blood flow.

That's the key contrast with ED medications like sildenafil (Viagra), which act on blood vessels to change blood flow. PT-141 is a different tool for a different part of the picture. If you're comparing the two, the PT-141 vs Viagra breakdown lays it out. PT-141 is not an ED drug and isn't positioned as one.

Desire vs blood flowED drugs work on the body's plumbing. PT-141 is studied for the brain's desire signal. That's why it can matter for women, where low desire, not blood flow, is often the missing piece.

What did the studies find in women?

In the RECONNECT trials, women using bremelanotide reported larger gains in sexual desire and larger drops in distress about low desire than women on placebo. Both were the trials' main goals, and both were met. Response rates ran roughly 58% on bremelanotide versus 36% on placebo, so a meaningful share of women noticed a difference, though not everyone did.

~6 million
premenopausal U.S. women live with persistent low desire plus distress
~10%
of U.S. women are affected by low desire with distress
Figures reflect published HSDD prevalence estimates; see sources.

Low desire with real distress is common and not a character flaw. It's often called HSDD in the research. pru covers it as an educational topic, not a disease it claims to treat. If you want the wider view of options, see best peptides for libido and peptides for sexual health.

What is the PT-141 dosage for women?

The studied branded dose in women is 1.75 mg injected under the skin about 45 minutes before intimacy, with no more than one dose in 24 hours and no more than eight doses a month. It's an on-demand peptide, not a daily one. Compounded PT-141 protocols are set by the prescribing physician and often start lower to gauge how you respond and to limit nausea.

QuestionReference from trials and labeling
How much1.75 mg (branded studied dose); compounded doses are set by your prescriber, often starting lower
WhenAbout 45 minutes before anticipated intimacy
How oftenNo more than one dose per 24 hours
Monthly capNo more than eight doses per month
RouteSmall subcutaneous (under-the-skin) injection
Studied PT-141 dosing reference for women

Your dose is a clinical decision, not a guess. A pru physician confirms what fits you. For more on timing and titration, see PT-141 dosage, and for delivery format, PT-141 nasal spray vs injection.

What are the side effects for women?

The most common side effect by far is nausea. In the trials about 40% of women reported it, usually peaking 30 to 60 minutes after the injection and easing within a few hours. Flushing (about 20%) and headache (about 11%) were next. Most effects were mild to moderate and tied to the dose.

  • Nausea, the main reason some women lower the dose or stop
  • Flushing and headache, usually short-lived
  • Modest, temporary rises in blood pressure and heart rate seen in trials
  • Darkening of skin or the gums in some people, linked to melanocortin activity

Because of the blood-pressure signal, PT-141 isn't right for people with uncontrolled high blood pressure or known heart disease. This is exactly what the physician review is for. The full rundown lives on PT-141 side effects.

How is pru's compounded PT-141 different from Vyleesi?

Vyleesi is the branded, FDA-approved bremelanotide product. pru's PT-141 is compounded, pharmacy-grade bremelanotide made by a licensed 503A pharmacy after a physician prescribes it. They share the same active molecule, but compounded PT-141 is not the branded drug and isn't marketed as the same as Vyleesi. Compounding lets the pharmacy tailor the dose and format to what the physician orders.

Plain termsSame active peptide, different products. pru's is pharmacy-grade compounded PT-141, not FDA-approved Vyleesi, and the two aren't interchangeable.

Who is PT-141 a fit for, and who should skip it?

PT-141 is studied for premenopausal women with low sexual desire that causes real distress, who want an on-demand option that works on the desire signal itself. It may fit women for whom the missing piece is wanting, not physical arousal. Evidence in postmenopausal women is thinner, which is one more reason a physician reviews your case.

  • Could be a fit: healthy adults bothered by low desire who prefer an as-needed peptide
  • Poor fit: uncontrolled high blood pressure or known cardiovascular disease
  • Poor fit: pregnancy, or trying to become pregnant
  • Always: a physician confirms fit before anything is prescribed

No peptide works for everyone, and pru can't promise a result. Oxytocin is another option some women explore for closeness and connection; see oxytocin for intimacy.

How pru handles PT-141 for women

pru is a telehealth platform for peptides done carefully. You select PT-141 with the help of guides like this one, and a licensed physician confirms it's a clinical fit for you. If approved, a licensed 503A pharmacy compounds and fills your pharmacy-grade PT-141.

A confident, relaxed woman in her late 30s at home in soft morning light, calm and at ease with a warm, unguarded smile
Image: pru

The medicine is sold separately and at cost, itemized, with no markup on the peptide itself. A membership of about $50 a month funds the platform and your care, not the drug price. You can see PT-141 on pru, browse sexual health and intimacy, or review membership and pricing. Being proactive about your intimacy and vitality is a smart, responsible choice, and pru exists to make that choice the accessible one: licensed physicians, pharmacy-grade medicine, at-cost pricing. Take the next step when you feel ready.

How it worksYou select, a physician confirms, a 503A pharmacy compounds. Peptide at cost, membership funds the platform.

Common questions

Does PT-141 work for women?
PT-141 is studied specifically in women. In the RECONNECT trials, about 1,200 premenopausal women used bremelanotide on demand and reported larger gains in desire and larger drops in distress than women on placebo, with response rates near 58% versus 36% for placebo. It doesn't work for everyone, and pru can't promise a result.
Is PT-141 the same as Vyleesi?
They share the same active peptide, bremelanotide, but they aren't the same product. Vyleesi is the branded, FDA-approved drug. pru offers compounded, pharmacy-grade PT-141 made by a licensed 503A pharmacy after a physician prescribes it. Compounded PT-141 is not the branded drug and shouldn't be treated as identical.
What is the PT-141 dosage for women?
The studied branded dose is 1.75 mg injected under the skin about 45 minutes before intimacy, with no more than one dose in 24 hours and no more than eight a month. Compounded protocols are set by the prescribing physician and often start lower to limit nausea. Your dose is a clinical decision.
How is PT-141 different from Viagra?
PT-141 works on desire pathways in the brain, while Viagra (sildenafil) works on blood flow. PT-141 is studied for the wanting side of desire; ED drugs act on the body's mechanics. PT-141 is not an ED drug. See the PT-141 vs Viagra guide for the full contrast.
What are the side effects of PT-141 in women?
The most common is nausea, reported by about 40% in trials, usually peaking 30 to 60 minutes after the dose and easing within a few hours. Flushing and headache are next. Trials also saw modest, temporary rises in blood pressure and heart rate, so it isn't a fit for people with uncontrolled high blood pressure or heart disease.
How is PT-141 taken?
It's a small under-the-skin injection used on demand, about 45 minutes before intimacy, not a daily pill. There is also interest in nasal-spray formats; see PT-141 nasal spray vs injection for how the delivery methods compare.
How does pru prescribe PT-141 for women?
You select PT-141 with the help of pru's guides, a licensed physician confirms it's a clinical fit, and a licensed 503A pharmacy compounds and fills your pharmacy-grade PT-141. The peptide is sold separately and at cost, and a roughly $50 monthly membership funds the platform and your care.
How does pru keep peptides affordable?
pru runs on an at-cost model. You pay one flat membership, and the medication is passed through at the pharmacy's price with no member markup. Because pru never marks the medication up, we have every reason to push its price down, not up. As pru grows and orders more, we negotiate lower pricing with our partner pharmacies, and those savings go straight to you. Healthcare pricing is usually hidden and inflated; pru is built to sit on your side of it: transparent, at cost, and fighting to make peptides more affordable as we scale.
Do the savings add up if I take more than one peptide?
Yes, and this is where pru's at-cost pricing saves you the most. Because pru never marks the medication up, every vial is priced at cost, so each peptide you add avoids the markup a typical provider builds in. If a physician has you on more than one peptide, or on a stack, that saving repeats on every vial, all under one flat $50 membership instead of a marked-up price on each. The more your protocol includes, the more the difference adds up, which makes doing it the right way a financially responsible choice, not an expensive one.

Want more like this?

Subscribe to get new articles delivered to your inbox. No spam, unsubscribe anytime.

All Articles